2017 - Member of Academia Europaea
Her scientific interests lie mostly in Microbiology, Colistin, Antibiotics, Klebsiella pneumoniae and Intensive care medicine. Her Microbiology study frequently draws parallels with other fields, such as Acinetobacter baumannii. Her Colistin study integrates concerns from other disciplines, such as Fosfomycin, Tigecycline, Pharmacology, Intensive care unit and Polymyxin.
Her Antibiotics research includes elements of Drug resistance and Staphylococcus aureus. The concepts of her Intensive care medicine study are interwoven with issues in Internal medicine and Medical prescription. Her research investigates the connection between Internal medicine and topics such as Bacteremia that intersect with problems in Endocarditis and Pneumonia.
Her primary areas of investigation include Microbiology, Internal medicine, Antibacterial agent, Antibiotics and Surgery. Her Microbiology study incorporates themes from Pseudomonas aeruginosa and Klebsiella pneumoniae. Helen Giamarellou studied Internal medicine and Gastroenterology that intersect with Immunology.
Her study explores the link between Antibacterial agent and topics such as Pharmacokinetics that cross with problems in Anesthesia. Her Antibiotics research is multidisciplinary, incorporating elements of Drug resistance, Antimicrobial, Pharmacology and Intensive care medicine. Her work deals with themes such as Tigecycline, Acinetobacter baumannii and Fosfomycin, which intersect with Colistin.
The scientist’s investigation covers issues in Microbiology, Klebsiella pneumoniae, Colistin, Intensive care medicine and Internal medicine. Her studies in Microbiology integrate themes in fields like Avibactam and Mutant. Her Klebsiella pneumoniae study combines topics from a wide range of disciplines, such as Minimum inhibitory concentration, Drug resistance, Polymyxin and Meropenem.
Her Colistin study is related to the wider topic of Antibiotics. The various areas that she examines in her Intensive care medicine study include Tigecycline, Randomized controlled trial and Anesthesiology. Her Internal medicine research includes themes of Surgery and Carbapenem.
Helen Giamarellou mostly deals with Internal medicine, Colistin, Intensive care medicine, Antibiotics and Tigecycline. Her Internal medicine research incorporates themes from Throat and Surgery. Her study in Colistin is interdisciplinary in nature, drawing from both Polymyxin, Pharmacology and Acinetobacter baumannii.
Her research in Acinetobacter baumannii intersects with topics in Minimum inhibitory concentration and Microbiology. The study incorporates disciplines such as Antimicrobial, Randomized controlled trial and Antibiotic resistance in addition to Intensive care medicine. She has included themes like Pseudomonas aeruginosa, Intensive care unit, Drug resistance and Fosfomycin in her Tigecycline study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Metallo-β-lactamases: a last frontier for β-lactams?
Giuseppe Cornaglia;Helen Giamarellou;Gian Maria Rossolini.
Lancet Infectious Diseases (2011)
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.
M Souli;I Galani;H Giamarellou.
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
D. Plachouras;M. Karvanen;L. E. Friberg;E. Papadomichelakis.
Antimicrobial Agents and Chemotherapy (2009)
Acinetobacter baumannii: a universal threat to public health?
Helen Giamarellou;Anastasia Antoniadou;Kyriaki Kanellakopoulou.
International Journal of Antimicrobial Agents (2008)
Multidrug-resistant Gram-negative infections: what are the treatment options?
Helen Giamarellou;Garyphallia Poulakou.
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Y. Carmeli;M. Akova;G. Cornaglia;G. L. Daikos.
Clinical Microbiology and Infection (2010)
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
Lennie P G Derde;Ben S Cooper;Herman Goossens;Surbhi Malhotra-Kumar.
Lancet Infectious Diseases (2014)
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
Maria Souli;Irene Galani;Anastasia Antoniadou;Evangelos Papadomichelakis.
Clinical Infectious Diseases (2010)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos;Helen Giamarellou.
Expert Opinion on Pharmacotherapy (2014)
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
Anastasia Antoniadou;Flora Kontopidou;Garifalia Poulakou;Evangelos Koratzanis.
Journal of Antimicrobial Chemotherapy (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: